AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|
21 C
New York
Monday, September 14, 2026

Tag: cause

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient...

SOHU.COM REPORTS SECOND QUARTER 2025 UNAUDITED FINANCIAL RESULTS

BEIJING, Aug. 4, 2025 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today...

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

Zepp Health Corporation Reports Second Quarter 2025 Unaudited Financial Results

MILPITAS, Calif., Aug. 3, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research

World's most successful athletic fundraiser aims to raise record $76 million BOSTON, Aug. 2, 2025 /PRNewswire/ -- This weekend, the Pan-Mass Challenge (PMC) unites more than...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta and Petco and Encourages Investors to Contact the...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sarepta (SRPT) or PetCo (WOOF) To Contact Him Directly To Discuss Their Options

SHARC Energy Announces Update on Convertible Debenture Financing

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

Alpayana Completes Privatization of Sierra Metals Inc.

TORONTO, Aug. 1, 2025 /CNW/ - Alpayana S.A.C. ("Alpayana") and Sierra Metals Inc. ("Amalco") announce today that Alpayana has completed the privatization of Sierra Metals...

The Keg Royalties Income Fund Obtains Unitholder Approval for the Transaction with Fairfax

Not for distribution to U.S. News wire services or dissemination in the U.S.

SKRR Exploration Inc. Announces Letter of Intent for Proposed Reverse Takeover Transaction with Kenz Global Resources Ltd.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, Aug. 1, 2025 /CNW/ - SKRR Exploration Inc. (TSXV: SKRR) (FSE:...

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August 1, 2025, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 90,000 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCause